A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of Flu Vaccine (Surface Antigen, Inactivated, Formulation 2010-2011) When Administered to Non-elderly Adult and Elderly Subjects.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Apr 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza virus vaccine (Primary)
Indications Influenza virus infections
Focus Pharmacodynamics

Most Recent Events

10 May 2011 Additional lead trial centre identified as reported by European Clinical Trials Database record.
10 May 2011 New source identified and integrated (European Clinical Trials Database record EudraCT2010-018583-17).
06 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight